| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd9f802b0fd9999e71e4e98dc348a0ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c98b883084a55b73a470bd5ccf091010
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69d5a2d8120a837cd8e6f2ed055e35ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8468373bcd310a67844741b1cb2ba20d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1409 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3293
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3145 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-31 |
| filingDate |
2006-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d43420edf94217d06fb731b27cda7a24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_722f0f0bae155b9931a2b7703bc45746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09ae25689aecf9de2be53f5bbcb8fa3e |
| publicationDate |
2007-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007057717-A3 |
| titleOfInvention |
Pharmaceutical device for the administration of substances to patients |
| abstract |
Biological materials such as vaccines can be stabilised in certain glassy materials soluble in water. It has been proposed to form these glassy materials as a powder suspended in a non-aqueous liquid for injection into a patient. This method is complicated by the need to find suitable compatible liquids and to stop the glassy particles from congregating in liquid. These problems have been obviated by supporting the glassy material on a porous membrane remote from the eluant. When the biological material requires administration, the eluant can be passed across the membrane dissolving the glass and causing the substance to be carried by the liquid into the patient. |
| priorityDate |
2005-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |